PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
March 19, 2026Current Oncology ReportsOpen Access

Revisiting the Immune Frontier in Soft Tissue Sarcomas

View Full Paper
Ask AI
Bookmark
Share

Authors

NBNadeem BilaniNANourhane Al AkoumRARusul Al-Marayaty

Discussion

Loading...

Member takes

Overview

This review shows enhanced treatment efficacy in soft tissue sarcomas, suggesting new combination strategies and cellular therapies.

Key Points

  • The review aims to synthesize recent advances in immunotherapy for soft tissue sarcomas and explore strategies to overcome treatment resistance.
  • Review of recent clinical trials and findings in soft tissue sarcomas treatment.
  • Analysis of immune checkpoint inhibitors and their efficacy in various STS subtypes.
  • Evaluation of combination therapies integrating chemotherapy and novel immune modulators.
  • Examination of engineered T-cell therapies and tumor microenvironment factors.
  • Efficacy of immune checkpoint inhibitors varies by histology, with significant activity in specific STS subtypes.
  • Combination treatments have shown enhanced antitumor effects in early-phase trials.
  • Engineered T-cell therapies are now standard care for synovial sarcoma and expanding to other types.
  • Characterization of the tumor microenvironment is improving patient selection and trial design.

Cite This Study

Bilani et al. (2026) studied this question.

synapsesocial.com/papers/69bb92f2496e729e62980a3ahttps://doi.org/10.1007/s11912-026-01761-y
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tumour-infiltrating lymphocyte therapy landscape: prospects and challenges2025 · 18 citations
  2. 2Efficacy and safety of nivolumab monotherapy in patients with unresectable clear cell sarcoma and alveolar soft part sarcoma (OSCAR Trial/NCCH1510)2024 · 14 citations
  3. 3ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs2024 · 11 citations
  4. 4A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature Review2023 · 7 citations
  5. 5Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma2020 · 111 citations